Yıl: 2022 Cilt: 44 Sayı: 6 Sayfa Aralığı: 603 - 607 Metin Dili: İngilizce DOI: 10.14744/etd.2022.39699 İndeks Tarihi: 20-05-2023

Evaluation of Subclinical Inflammation in Children with Premature Adrenarche

Öz:
Objective: The objectives of this study were to compare the serum inflammatory markers, interleukin-6 (IL-6), highly sensi- tive C-reactive protein (hs-CRP), and fetuin-A, in patients with premature adrenarche (PA) and the control group. Materials and Methods: This single-center cross-sectional study included 85 non-obese and pre-pubertal children. After 8–12 h of fasting, blood glucose, HDL, LDL, triglyceride, cholesterol, insulin, dehydroepiandrosterone sulfate, total testos- terone, 17-OH PG, IL-6, hs-CRP, and Fetuin-A levels were measured and compared in a convenience sample of PA (n=35) and a healthy volunteers of control (n=50) group. Results: The mean age (7.34±0.62 years vs. 7.09±0.77 years, respectively) and sex (82% girl vs. 80% girl, respectively) of the PA and control groups were similar (p>0.05). Fasting insulin levels (10.9±6.21 Uu/mL vs. 7.4±5.9 Uu/mL; p<0.001), HOMA-IR (2.06±0.63 vs. 1.36±1.00; p=0.017), FGIR (11.31±5.60 vs. 16.46±8.52; p=0.004), and QUICKI (0.35±0.02 vs. 0.37±0.03; p<0.001) levels were different in PA and control groups. IL-6 level higher in PA group than controls [2.7 (3.30) pg/mL vs. 3.02 (1.31) pg/mL, p=0.035], while plasma Fetuin-A [522.02 (715.86) mg/L; 519.4 (945.97) mg/L, p=0.434] and hs-CRP [0.73 (1.02) mg/dL; 1.0 (1.12) mg/dL, p=0.439] levels were similar. IL-6 cutoff value for PA was calculated as 2.06 with 72.7% sensitivity and 48.8% specificity for all study groups (AUC=0.641, p=0.036). Conclusion: The high IL-6 levels may be an indicator of chronic subclinical inflammation in PA cases. These children should be followed closely in terms of metabolic disorders.
Anahtar Kelime:

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
  • 1. Rosenfield RL. Normal and premature adrenarche. Endocr Rev 2021; 42(6): 783–814.
  • 2. Ibáñez L, Dimartino-Nardi J, Potau N, Saenger P. Premature adre- narche--normal variant or forerunner of adult disease? Endocr Rev 2000; 21(6): 671–96.
  • 3. Mäntyselkä A, Jääskeläinen J, Lindi V, Viitasalo A, Tompuri T, Vou- tilainen R, et al. The presentation of adrenarche is sexually dimor - phic and modified by body adiposity. J Clin Endocrinol Metab 2014; 99(10): 3889–94.
  • 4. Ibáñez L, Potau N, Chacon P, Pascual C, Carrascosa A. Hyperinsuli- naemia, dyslipaemia and cardiovascular risk in girls with a history of premature pubarche. Diabetologia 1998; 41(9): 1057–63.
  • 5. Güven A, Cinaz P, Bideci A. Is premature adrenarche a risk factor for atherogenesis?. Pediatr Int 2005; 47(1): 20–5.
  • 6. Utriainen P, Jääskeläinen J, Gröhn O, Kuusisto J, Pulkki K, Voutilain- en R. Circulating TNF-Alpha and IL-6 concentrations and TNF-Alpha -308 G > A polymorphism in children with premature adrenarche. Front Endocrinol (Lausanne) 2010; 1:1–6.
  • 7. Mathew RP, Byrne DW, Linton MF, Vaughan DE, Fazio S, Russell WE. Evidence of metabolic syndrome in lean children with premature pubarche at diagnosis. Metabolism 2008; 57(6): 733–40.
  • 8. Livadas S, Dracopoulou M, Vasileiadi K, Lazaropoulou C, Magiakou MA, Xekouki P, et al. Elevated coagulation and inflammatory mark- ers in adolescents with a history of premature adrenarche. Metabolism 2009; 58(4): 576–81.
  • 9. Gabay C. Interleukin-6 and chronic inflammation. Arthritis Res Ther 2006; 8(Suppl 2): S3.
  • 10. Scheller J, Chalaris A, Schmidt-Arras D, Rose-John S. The pro- and anti-inflammatory properties of the cytokine interleukin-6. Biochim Biophys Acta 2011; 1813(5): 878–88.
  • 11. Yao Z, Zhang Y, Wu H. Regulation of C-reactive protein conformation in inflammation. Inflamm Res 2019; 68(10): 815–23.
  • 12. Castro AR, Silva SO, Soares SC. The use of high sensitivity C-Reactive protein in cardiovascular disease detection. J Pharm Pharm Sci 2018; 21(1): 496–503.
  • 13. Icer MA, Yıldıran H. Effects of fetuin-A with diverse functions and mul- tiple mechanisms on human health. Clin Biochem 2021; 88: 1–10.
  • 14. Hennige AM, Staiger H, Wicke C, Machicao F, Fritsche A, Häring HU, et al. Fetuin-A induces cytokine expression and suppresses adiponectin production. PLoS One 2008; 3(3): e1765.
  • 15. Stefan N, Hennige AM, Staiger H, Machann J, Schick F, Kröber SM, et al. Alpha2-Heremans-Schmid glycoprotein/fetuin-A is associated with insulin resistance and fat accumulation in the liver in humans. Diabetes Care 2006; 29(4): 853–7.
  • 16. Bundak R, Furman A, Gunoz H, Darendeliler F, Bas F, Neyzi O. Body mass index references for Turkish children. Acta Paediatr 2006; 95(2): 194–8.
  • 17. Placzkowska S, Pawlik-Sobecka L, Kokot I, Piwowar A. Indirect insulin resistance detection: Current clinical trends and laboratory limitations. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2019; 163(3): 187–99.
  • 18. Silfen ME, Manibo AM, McMahon DJ, Levine LS, Murphy AR, Ober- field SE. Comparison of simple measures of insulin sensitivity in young girls with premature adrenarche: the fasting glucose to insulin ratio may be a simple and useful measure. J Clin Endocrinol Metab 2001; 86(6): 2863–8.
  • 19. Sapunar J, Aguilar-Farías N, Navarro J, Araneda G, Chandía-Poblete D, Manríquez V, et al. High prevalence of dyslipidemia and high ath- erogenic index of plasma in children and adolescents. [Article in Span- ish]. Rev Med Chil 2018; 146(10): 1112–2.
  • 20. Arrais RF, Dib SA. The hypothalamus-pituitary-ovary axis and type 1 diabetes mellitus: a mini review. Hum Reprod 2006; 21(2): 327–37.
  • 21. Utriainen P, Jääskeläinen J, Romppanen J, Voutilainen R. Childhood metabolic syndrome and its components in premature adrenarche. J Clin Endocrinol Metab 2007; 92(11): 4282–5.
  • 22. Escobar-Morreale HF, Luque-Ramírez M, González F. Circulating in- flammatory markers in polycystic ovary syndrome: a systematic review and metaanalysis. Fertil Steril 2011; 95(3): 1048–58.e582.
  • 23. Mauras N, Delgiorno C, Kollman C, Bird K, Morgan M, Sweeten S, et al. Obesity without established comorbidities of the metabolic syn- drome is associated with a proinflammatory and prothrombotic state, even before the onset of puberty in children. J Clin Endocrinol Metab 2010; 95(3): 1060–8.
  • 24. Ibáñez L, Potau N, Ong K, Dunger DB, De Zegher F. Increased bone mineral density and serum leptin in non-obese girls with precocious pubarche: relation to low birthweight and hyperinsulinism. Horm Res 2000; 54(4): 192–7.
  • 25. Ibáñez L, Aulesa C, Potau N, Ong K, Dunger DB, de Zegher F. Plas- minogen activator inhibitor-1 in girls with precocious pubarche: a pre- menarcheal marker for polycystic ovary syndrome?. Pediatr Res 2002; 51(2): 244–8.
  • 26. Ibanez L, Potau N, Zampolli M, Prat N, Virdis R, Vicens-Calvet Eet al. Hyperinsulinemia in postpubertal girls with a history of premature pubarche and functional ovarian hyperandrogenism. J Clin Endocrinol Metab 1996; 81(3): 1237–43.
  • 27. Ibáñez L, Potau N, Zampolli M, Riqué S, Saenger P, Carrascosa A. Hy- perinsulinemia and decreased insulin-like growth factor-binding protein-1 are common features in prepubertal and pubertal girls with a history of premature pubarche. J Clin Endocrinol Metab 1997; 82(7): 2283–8.
  • 28. Silfen ME, Manibo AM, Ferin M, McMahon DJ, Levine LS, Oberfield SE. Elevated free IGF-I levels in prepubertal Hispanic girls with pre- mature adrenarche: relationship with hyperandrogenism and insulin sensitivity. J Clin Endocrinol Metab 2002; 87(1): 398–403.
  • 29. Meas T, Chevenne D, Thibaud E, Léger J, Cabrol S, Czernichow P, et al. Endocrine consequences of premature pubarche in post-pubertal Caucasian girls. Clin Endocrinol (Oxf) 2002; 57(1): 101–6.
APA Köylü G, ÇELİK N, DOĞAN H (2022). Evaluation of Subclinical Inflammation in Children with Premature Adrenarche. , 603 - 607. 10.14744/etd.2022.39699
Chicago Köylü Gözde,ÇELİK Nurullah,DOĞAN Halef Okan Evaluation of Subclinical Inflammation in Children with Premature Adrenarche. (2022): 603 - 607. 10.14744/etd.2022.39699
MLA Köylü Gözde,ÇELİK Nurullah,DOĞAN Halef Okan Evaluation of Subclinical Inflammation in Children with Premature Adrenarche. , 2022, ss.603 - 607. 10.14744/etd.2022.39699
AMA Köylü G,ÇELİK N,DOĞAN H Evaluation of Subclinical Inflammation in Children with Premature Adrenarche. . 2022; 603 - 607. 10.14744/etd.2022.39699
Vancouver Köylü G,ÇELİK N,DOĞAN H Evaluation of Subclinical Inflammation in Children with Premature Adrenarche. . 2022; 603 - 607. 10.14744/etd.2022.39699
IEEE Köylü G,ÇELİK N,DOĞAN H "Evaluation of Subclinical Inflammation in Children with Premature Adrenarche." , ss.603 - 607, 2022. 10.14744/etd.2022.39699
ISNAD Köylü, Gözde vd. "Evaluation of Subclinical Inflammation in Children with Premature Adrenarche". (2022), 603-607. https://doi.org/10.14744/etd.2022.39699
APA Köylü G, ÇELİK N, DOĞAN H (2022). Evaluation of Subclinical Inflammation in Children with Premature Adrenarche. Erciyes Medical Journal, 44(6), 603 - 607. 10.14744/etd.2022.39699
Chicago Köylü Gözde,ÇELİK Nurullah,DOĞAN Halef Okan Evaluation of Subclinical Inflammation in Children with Premature Adrenarche. Erciyes Medical Journal 44, no.6 (2022): 603 - 607. 10.14744/etd.2022.39699
MLA Köylü Gözde,ÇELİK Nurullah,DOĞAN Halef Okan Evaluation of Subclinical Inflammation in Children with Premature Adrenarche. Erciyes Medical Journal, vol.44, no.6, 2022, ss.603 - 607. 10.14744/etd.2022.39699
AMA Köylü G,ÇELİK N,DOĞAN H Evaluation of Subclinical Inflammation in Children with Premature Adrenarche. Erciyes Medical Journal. 2022; 44(6): 603 - 607. 10.14744/etd.2022.39699
Vancouver Köylü G,ÇELİK N,DOĞAN H Evaluation of Subclinical Inflammation in Children with Premature Adrenarche. Erciyes Medical Journal. 2022; 44(6): 603 - 607. 10.14744/etd.2022.39699
IEEE Köylü G,ÇELİK N,DOĞAN H "Evaluation of Subclinical Inflammation in Children with Premature Adrenarche." Erciyes Medical Journal, 44, ss.603 - 607, 2022. 10.14744/etd.2022.39699
ISNAD Köylü, Gözde vd. "Evaluation of Subclinical Inflammation in Children with Premature Adrenarche". Erciyes Medical Journal 44/6 (2022), 603-607. https://doi.org/10.14744/etd.2022.39699